101
Views
14
CrossRef citations to date
0
Altmetric
Special Topic: Progress and Challenges in Vaccinology

HIV/AIDS Vaccines: A Need for New Concepts?

&
Pages 447-471 | Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Antonella Caputo, Riccardo Gavioli, Stefania Bellino, Olimpia Longo, Antonella Tripiciano, Vittorio Francavilla, Cecilia Sgadari, Giovanni Paniccia, Fausto Titti, Aurelio Cafaro, Flavia Ferrantelli, Paolo Monini, Fabrizio Ensoli & Barbara Ensoli. (2009) HIV-1 Tat-Based Vaccines: An Overview and Perspectives in the Field of HIV/AIDS Vaccine Development. International Reviews of Immunology 28:5, pages 285-334.
Read now

Articles from other publishers (13)

Marc P. Girard & Wayne C. Koff. 2018. Plotkin's Vaccines. Plotkin's Vaccines 400 429.e25 .
Jann Hau & Steven SchapiroLezlee Coghlan. 2013. Handbook of Laboratory Animal Science, Volume III, Third Edition. Handbook of Laboratory Animal Science, Volume III, Third Edition 219 300 .
Sanna Nyström, Andreas Bråve, Tina Falkeborn, Claudia Devito, Björn Rissiek, Daniel Johansson, Ulf Schröder, Satoshi Uematsu, Shizuo Akira, Jorma Hinkula & Steven Applequist. (2013) DNA-Encoded Flagellin Activates Toll-Like Receptor 5 (TLR5), Nod-like Receptor Family CARD Domain-Containing Protein 4 (NRLC4), and Acts as an Epidermal, Systemic, and Mucosal-Adjuvant. Vaccines 1:4, pages 415-443.
Crossref
Hongmei Zhang, Yuan-Fang Wang, Chen-Hsiang Shen, Johnson Agniswamy, Kalapala Venkateswara Rao, Chun-Xiao Xu, Arun K. Ghosh, Robert W. Harrison & Irene T. Weber. (2013) Novel P2 Tris-tetrahydrofuran Group in Antiviral Compound 1 (GRL-0519) Fills the S2 Binding Pocket of Selected Mutants of HIV-1 Protease . Journal of Medicinal Chemistry 56:3, pages 1074-1083.
Crossref
Marc P. Girard & Wayne C. Koff. 2013. Vaccines. Vaccines 1097 1121 .
Andrew J. Mouland & Miroslav P. Milev. 2012. Dyneins. Dyneins 560 583 .
Marc P. Girard, Saladin Osmanov, Olga M. Assossou & Marie-Paule Kieny. (2011) Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review. Vaccine 29:37, pages 6191-6218.
Crossref
Flavia Ferrantelli, Maria Teresa Maggiorella, Ilaria Schiavoni, Leonardo Sernicola, Erika Olivieri, Stefania Farcomeni, Maria Rosaria Pavone-Cossut, Sonia Moretti, Roberto Belli, Barbara Collacchi, Indresh K. Srivastava, Fausto Titti, Aurelio Cafaro, Susan W. Barnett & Barbara Ensoli. (2011) A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study. Vaccine 29:16, pages 2918-2932.
Crossref
Anja Krause & Stefan Worgall. (2011) Delivery of antigens by viral vectors for vaccination. Therapeutic Delivery 2:1, pages 51-70.
Crossref
Irene T. Weber & Yuan-Fang Wang. 2010. Aspartic Acid Proteases as Therapeutic Targets. Aspartic Acid Proteases as Therapeutic Targets 107 137 .
Michael J. Dapp, Christine L. Clouser, Steven Patterson & Louis M. Mansky. (2009) 5-Azacytidine Can Induce Lethal Mutagenesis in Human Immunodeficiency Virus Type 1. Journal of Virology 83:22, pages 11950-11958.
Crossref
Anastas PashovSwetha Garimalla, Behjatolah Monzavi-KarbassiThomas Kieber-Emmons. (2009) Carbohydrate targets in HIV vaccine research: lessons from failures. Immunotherapy 1:5, pages 777-794.
Crossref
Bruno Gryseels, Alimuddin Zumla, Marita Troye-Blomberg, Marie Paule Kieny, Gianluca Quaglio, Andreas Holtel, Hannu Laang, Manuel Romaris, Maria Teresa De Magistris, Ana Nieto Nuez, Ole F Olesen, Rachida Ghalouci & Anna Lönnroth. (2009) European Union conference on poverty-related diseases research. The Lancet Infectious Diseases 9:6, pages 334-337.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.